Evidence map›Paper›PMID 30049709›Full record

ArticleJournal of lipid research2018

Novel

Katja Brunner, Constance M John, Nancy J Phillips, Dagmar G Alber, Matthew R Gemmell, Richard Hansen, Hans L Nielsen, Georgina L Hold, Mona Bajaj-Elliott, Gary A Jarvis

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of lipid research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Small worms big discoveries:Frontiers in cellular and infection microbiology · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 4 countries.

Katja BrunnerInfection, Immunity and Inflammation Programme, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Constance M JohnCenter for Immunochemistry, Veterans Affairs Medical Center, San Francisco, CA.
Nancy J PhillipsDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA.
Dagmar G AlberInfection, Immunity and Inflammation Programme, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Matthew R GemmellCenter for Genome-Enabled Biology and Medicine, School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Richard HansenDepartment of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow, United Kingdom.
Hans L NielsenDepartment of Infectious Diseases Aalborg University Hospital, Aalborg, Denmark.
Georgina L HoldSt George and Sutherland Clinical School, University of New South Wales, Sydney, Australia.
Mona Bajaj-ElliottInfection, Immunity and Inflammation Programme, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Gary A JarvisCenter for Immunochemistry, Veterans Affairs Medical Center, San Francisco, CA gary.jarvis@ucsf.edu.
University College London · GBSan Francisco VA Medical Center · USAalborg University Hospital · DKRoyal Hospital for Children · GBSutherland Hospital · AUUniversity of Aberdeen · GBUniversity of California, San Francisco · US

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Leigh Clarke · 1999 to 2026
$209.7M
Structural Characterization of Polypeptides, Protein Complexes, OligosaccharidesS10RR029446 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITKOWSKA, H. EWA · 2010 to 2010
$1.0M
Targeting of LOS for Treatment of Antibiotic-Resistant Neisseria gonorrhoeaeI01BX000727 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI JARVIS, GARY A · 2011 to 2025
–
BLRD VA I01 BX000727Chief Scientist Office CAF/08/01NCI NIH HHS P30 CA082103NCRR NIH HHS S10 RR029446
6 · The paper itself

Abstract

The pathogenicity of

Indexed as

CampylobacterCell LineGenomicsHumansInflammationLipid ALipopolysaccharidesSignal TransductionTumor Necrosis Factor-alphaVirulenceLipid ALipopolysaccharidesTumor Necrosis Factor-alphacytokinesglycolipidsinflammationlipid Amass spectrometrymonocytesphosphorylationtoll-like receptors

Identifiers

PMID30049709
PMCPMC6168313
OpenAlexW2883153492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.